Showing posts with label St Jude Medical. Show all posts
Showing posts with label St Jude Medical. Show all posts

Monday, January 9, 2012

Apache (APA) (STJ) (TDC) (V) (APO) (APOL) Price Targets Changed

Apache (NYSE: APA), St. Jude Medical, Inc. (NYSE: STJ), Teradata Co. (NYSE: TDC), Visa Inc. (NYSE: V), American Community Properties Trust (NYSE: APO) and Apollo Group, Inc. (NASDAQ: APOL) had price targets on them adjusted by analysts.

St. Jude Medical, Inc. (STJ) had its price target lowered by Barclays Capital (NYSE:BCS) from $51.00 to $48.00. They have an “Overweight” rating on the company.

Teradata Co. (TDC) had its price target lowered by UBS AG (NYSE:UBS) from $62.00 to $54.00. They have a “Neutral” rating on the company.

Visa Inc. (V) had its price target raised by Guggenheim to $108.00. They have a “Neutral” rating on the company.

Apache (APA) had its price target lowered by Oppenheimer to $120.00.

American Community Properties Trust (APO) had its price target

lowered by Barclays Capital from $24.00 to $21.00. They have an “Overweight” rating on the company.

Apollo Group, Inc. (APOL) had its price target raised by Citigroup (NYSE:C) to $58.00.

Friday, November 18, 2011

Transdigm (TDG) (CHOP) (SPRD) (STJ) (CHSI) (CHTP) Ratings, Price Targets

Transdigm Group (TDG), China Gerui Advanced Materials Group Limited (CHOP), Spreadtrum (SPRD), St. Jude Medical, Inc. (STJ), Catalyst Health Solutions, Inc. (CHSI) and Chelsea Therapeutics International (CHTP) ratings and price targets.

RBC Capital raised its price target on Transdigm Group (TDG) from $106.00 to $110.00. They have a “Top Pick” rating on the company.

Oppenheimer initiated coverage on China Gerui Advanced Materials Group Limited (CHOP). They placed an “Outperform” rating and a price target of $6.00 on the company.

Credit Suisse initiated coverage on Spreadtrum (SPRD). They placed an “Outperform” rating on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its “Overweight” on St. Jude Medical, Inc. (STJ). They have a price target of $55.00 on the company.

Stifel Nicolaus initiated coverage on Catalyst Health Solutions, Inc. (CHSI). They placed a “Hold” rating on the company.

Wedbush raised its price target on Chelsea Therapeutics International (CHTP) to $11.00.

Wednesday, October 26, 2011

Petrochina (PTR) (NSRGY) (STJ) (WSH) Upgraded

Petrochina (NYSE: PTR), Nestle (OTC: NSRGY), St. Jude Medical, Inc. (NYSE: STJ) and Willis Group Holdings PLC (NYSE: WSH) were upgraded by analysts.

Nestle (NSRGY) was upgraded by RBS from a “Hold” rating to a “Buy” rating.

Petrochina (PTR) was upgraded by Goldman Sachs (NYSE:GS) from a “Sell” rating to a “Neutral” rating.

St. Jude Medical, Inc. (STJ) was upgraded by Mizuho from a “Neutral” rating to a “Buy” rating.

Willis Group Holdings PLC (WSH) was upgraded by Barclays Capital from an “Equal Weight” rating to an “Overweight” rating.

Friday, September 23, 2011

Stryker (SYK) (CPTS) (STJ) (CPX) (SKX) (CRIS) Get New Coverage

Stryker (NYSE: SYK), Conceptus, Inc. (NASDAQ: CPTS), St. Jude Medical, Inc. (NYSE: STJ), Complete Production Services Inc (NYSE: CPX), Skechers USA, Inc. (NYSE: SKX) and Curis, Inc. (NASDAQ: CRIS) getting new coverage from analysts.

Kaufman Brothers initiated coverage on Stryker (SYK). They placed a “Buy” rating and a price target of $57.00 on the company.

Kaufman Brothers initiated coverage on Conceptus, Inc. (CPTS). They placed a “Hold” rating and a price target of $11.00 on the company.

Kaufman Brothers initiated coverage on St. Jude Medical, Inc. (STJ). They placed a “Buy” rating and a price target of $50.00 on the company.

Morgan Keegan initiated coverage on Complete Production Services Inc (CPX). They placed an “Outperform” rating and a price target of $45.00 on the company.

Auriga initiated coverage on Skechers USA, Inc. (SKX). They placed a “Hold” rating and a price target of $16.00 on the company.

MLV Capital initiated coverage on Curis, Inc. (CRIS). They placed a “Buy” rating and a price target of $8.50 on the company.

Thursday, August 25, 2011

Thoratec (THOR) (OVTI) (PSUN) (RJF) (STJ) Price Targets Changed

Thoratec (NASDAQ: THOR), OmniVision Technologies, Inc. (NASDAQ: OVTI), Pacific Sunwear of California, Inc. (NASDAQ: PSUN), Raymond James (NYSE: RJF) and St. Jude Medical, Inc. (NYSE: STJ) price targets adjusted by analysts.

OmniVision Technologies, Inc. (OVTI) had its price target lowered by Wedbush from $45.00 to $38.00. They have an “Outperform” rating on the company.

Pacific Sunwear of California, Inc. (PSUN) had its price target lowered by Wedbush from $3.50 to $2.00. They have an “Underperform” rating on the company.

Raymond James (RJF) had its price target lowered by Ticonderoga from $37.00 to $34.00. They have a “Buy” rating on the company.

St. Jude Medical, Inc. (STJ) had its price target lowered by Morgan Keegan from $60.00 to $53.00. They have an “Outperform” rating on the company.

Thoratec (THOR) had its price target lowered by Morgan Keegan from $35.00 to $32.00. They have a “Market Perform” rating on the company.

Friday, July 22, 2011

Xilinx (XLNX) (STJ) (WU) (AVGO) (BANF) Ratings Reiterated

Xilinx, Inc. (NASDAQ: XLNX), St. Jude Medical, Inc. (NYSE: STJ), The Western Union Company (NYSE: WU), Avago Technologies (NASDAQ: AVGO) and BancFirst Co. (NASDAQ: BANF) have ratings reiterated.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Xilinx, Inc. (XLNX).

Citigroup (NYSE:C) reiterated its "Sell" rating on St. Jude Medical, Inc. (STJ).

Wells Fargo & Co. reiterated its "Outperform" rating on The Western Union Company (WU).

Citigroup maintains its "Buy" rating on Avago Technologies (AVGO). They have a price target of $45.00 on the company.

KBW reiterated a "Market Perform" rating on BancFirst Co. (BANF).

Tuesday, July 19, 2011

Arch Coal (ACI) (BSYBY) (EOG) (EXC) (ITYBY) (STJ) Upgraded by Analysts

Arch Coal, Inc. (NYSE: ACI) was upgraded by Citigroup from a “neutral” rating to a “buy” rating. They cited valuation as the catalyst behind the call.

British Sky Broadcasting Group (BSYBY) was upgraded by UBS AG from a “neutral” rating to a “buy” rating.

EOG Resources (EOG) was upgraded by FBR Capital from a “market perform” rating to an “outperform” rating. They have a price target of $130.00 on the company.

Exelon Co. (EXC) was upgraded by Ticonderoga from a “neutral” rating to a “buy” rating. They have price target of $49.00 on the company.

Imperial Tobacco Group (ITYBY) was upgraded by Citigroup (NYSE:C) from a “hold” rating to a “buy” rating.

St. Jude Medical, Inc. (STJ) was upgraded by Barclays Capital from an “equal weight” rating to an “overweight” rating. They cited valuation as the catalyst behind their call.

Friday, May 13, 2011

Dividends on (NWL) (PCH) (PKY) (FINL) (STJ) Declared

Newell Rubbermaid (NYSE:NWL), Potlatch Corp. (NASDAQ:PCH), Parkway Properties (NYSE:PKY), Rockville Financial (NASDAQ:FINL) and St. Jude Medical Inc. (NYSE:STJ) declare dividends.

The Board of Directors of Newell Rubbermaid (NWL) declared a quarterly common stock dividend of $0.08 per share payable 6/15/11 to shareholders of record at the close of business on 5/31/11.

The Board of Directors of Potlatch Corp. (PCH) declared a quarterly common stock dividend of $0.51 per share payable 6/24/11 to shareholders of record at the close of business on 6/3/11.

The Board of Directors of Parkway Properties (PKY) declared a quarterly common stock dividend of $0.075 per share payable 6/29/11 to shareholders of record at the close of business on 6/10/11.

The Board of Directors of Rockville Financial (FINL) declared a quarterly common stock dividend of $0.1625 per share payable 5/31/11 to shareholders of record at the close of business on 5/23/11.

The Board of Directors of St. Jude Medical Inc. (STJ) declared a second quarter common stock dividend of $0.21 per share payable 7/29/11 to shareholders of record at the close of business on 6/30/11.

Monday, May 2, 2011

Dividend Yields for (BAX) (MDT) (BDX) (CAH) (STJ)

Indicated dividend yields for Standard & Poor's 500 Index companies Baxter International Inc (BAX), Medtronic Inc (MDT), Becton Dickinson and Co (BDX), Cardinal Health Inc (CAH) and St Jude Medical Inc. (STJ).

These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.

Baxter International Inc (BAX) has a dividend yield of 2.18 percent on a declared dividend of $0.31. The payout ratio is 31.4 percent.

Medtronic Inc (MDT) has a dividend yield of 2.16 percent on a declared dividend of $0.23. The payout ratio is 26.2 percent.

Becton Dickinson and Co (BDX) has a dividend yield of 1.91 percent on a declared dividend of $0.41. The payout ratio is 29.1 percent.

Cardinal Health Inc (CAH) has a dividend yield of 1.78 percent on a declared dividend of $0.20. The payout ratio is 27.2 percent.

St Jude Medical Inc (STJ) has a dividend yield of 1.57 percent on a declared dividend of $0.21. The payout ratio is na.

Wednesday, April 20, 2011

St. Jude Medical (STJ) Earnings Drop Ends Streak

Shares of St. Jude Medical (NYSE:STJ) are trading strong even after a disappointing quarter where net income for St. Jude Medical, Inc. was down to $233.4 million, or 71 cents a share, vs. $238.6 million, or 73 cents a share last year in the same quarter, a decline of 2.2 percent.

Revenue jumped for the quarter, rising 9 percent to $1.38 billion.

St. Jude Medical missed on the average analyst estimate of 78 cents a share. Estimates ranged from 77 cents a share to 80 cents a share.

St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “During the first quarter, we continued to make good progress in developing the new growth drivers we need to return to double-digit sales growth on a sustainable basis. Our gross margin has strengthened, we have continued to invest in research and development at an elevated rate, and our sales and earnings growth outlook have both improved. We are off to a good start making 2011 another very successful year for St. Jude Medical.”

Major competitors of St. Jude Medical include Medtronic, Inc. (NYSE:MDT), Boston Scientific Corporation (NYSE:BSX), Intuitive Surgical, Inc. (NASDAQ:ISRG), Johnson & Johnson (NYSE:JNJ), and Edwards Lifesciences Corp. (NYSE:EW).

St. Jude Medical was trading at $52.75, gaining $1.75, or 3.43 percent, as of 1:22 PM EDT.

Wednesday, March 16, 2011

Medical Device Makers (VOLC) (EW) (XRAY) Among Hardest Hit in Japan

A large number of sectors have been hit hard in Japan, depending on the exposure they have to the country, and one not mentioned too much so far is the medical devices market, where those with the most exposure to Japan are Volcano Corp (NASDAQ:VOLC) Edwards Lifesciences Corp (NYSE:EW) and Dentsply International Inc (NASDAQ:XRAY).

About 30 percent of revenue generated by Volcano comes from Japan. Dentsply said key suppliers have been disrupted and has withdrawn its earnings guidance for 2011. Edwards Lifesciences Corp., which makes heart valves, generates about 17 percent of its revenue in Japan. At worst, Edwards sees disruptions being temporary and see no materially impact financial results from the earthquake damage.

Even so, analysts say every company should experience some degree of loss of sales as a result of the natural disaster.

Others device makers with significant exposure in Japan are Boston Scientific Corp (NYSE:BSX), with 12 percent of total sales in Japan, St Jude Medical Inc (NYSE:STJ) and Wright Medical Group Inc (NASDAQ:WMGI) at 11 percent each, Stryker Corp (NYSE:SYK) at 10 percent and Zimmer Holdings Inc (NYSE:ZMH) at 9 percent.

Larger diversified firms with less exposure are Medtronic Inc (NYSE:MDT), Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT) with from 5 percent to 6 percent of sales coming from Japan.

Of drugmakers, the largest exposure is Merck & Co Inc (NYSE:MRK) with about 8 percent of sales coming from Japan. Bristol Myers Squibb (NYSE:BMY) only has about 3 percent of sales come from there.

Volcano Corp. closed Tuesday at $23.56, down $1.21, or 4.88 percent. Edwards Lifesciences closed at $86.23, dropping $2.23, or 2.52 percent. Densply closed at $35.63, falling $1.55, or 4.17 percent.

Wednesday, January 19, 2011

St. Jude Medical (NYSE:STJ) Releasing 'Quadra CRT-D' Earlier than Thought

With the news St. Jude Medical (NYSE:STJ) will be launching their game-changing Quadra CRT-D earlier than originally anticipated, they could have about a two-year lead on their nearest competitor, depending on where it is released.

It could be released as early as May, with a full roll-out soon after.

Jefferies noted, "Boston (NYSE:BSX) is not expecting a quadripolar lead until mid-2013 in EU and likely 2014 in the U.S.; Medtronic (NYSE:MDT) appears to be slightly ahead and may have a European product in mid-late 2012 at the earliest."

Jefferies said they're raising their full year 2010 EPS estimates by $0.01 to $3.00 and their full year 2011 to $3.36 from $3.25 in response.

They are reiterating their "Buy" rating on St. Jude Medical (STJ), which closed Tuesday at $41.93, up $0.46, or 1.11 percent. Jefferies (NYSE:JEF) boosted their price target on St. Jude from $46 to $49.

Friday, January 14, 2011

St. Jude Medical (NYSE:STJ) Exceeds Expectations in Most Categories

The pre-announcement by St. Jude Medical (NYSE:STJ) showed it has performed strongly in the quarter, exceeding expectations in all categories with the exception of pacemakers.

Barclays said, "Before the market opened on January 12, 2011, St. Jude Medical pre-announced 4Q10 results, expecting top-line results above guidance and consensus, with EPS near the top end of its previously issued range of $0.72-$0.74. The results were broadly strong on weak comps (we note that one less selling week negatively impacted 4Q09 results by -5% and we estimate a similar effect on the positive side in 4Q10). Although we had anticipated a stronger 4Q10 based on y/y comparisons, top-line results still outpaced our estimates in every category but pacemakers. Key ICD sales increased 18% ex-fx, including 15% in the US and an estimated 22% OUS (an 800 bps sequential increase). While we were encouraged by STJ's strong results in a difficult environment, valuation continues to keep us on the sidelines."

Barclays reiterates an "Equalweight" rating on St. Jude Medical, which closed Thursday at $41.60, dropping $0.13, or 0.31 percent. Barclays has a price target on St. Jude of $45.